Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5624737 | Alzheimer's & Dementia | 2011 | 11 Pages |
Abstract
In this study, no difference in the rates of TBV change between the two periods was observed; however, memantine treatment was found to be associated with slowing of right hippocampal atrophy, and with improvement on one test of executive functioning as well as a test of confrontation naming ability. Trials using structural magnetic resonance imaging and a delayed-start design may be a feasible option for the assessment of treatments for AD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Michael W. Weiner, Carl Sadowsky, Judith Saxton, Robert K. Hofbauer, Stephen M. Graham, Sung Yun Yu, Shaoyi Li, Hai-An Hsu, Joyce Suhy, Moshe Fridman, James L. Perhach,